Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Isoliquiritigenin suppresses the proliferation and induced apoptosis via miR-32/LATS2/Wnt in nasopharyngeal carcinoma
Tingting Wang, Zhen-Zhang Chen, Peng Xie, et al.
European Journal of Pharmacology (2019) Vol. 856, pp. 172352-172352
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Chalcone Derivatives: Role in Anticancer Therapy
Yang Ouyang, Juanjuan Li, Xinyue Chen, et al.
Biomolecules (2021) Vol. 11, Iss. 6, pp. 894-894
Open Access | Times Cited: 239
Molecular mechanisms underlying the anticancer activities of licorice flavonoids
Zhixin Zhang, Lin Yang, Jiaming Hou, et al.
Journal of Ethnopharmacology (2020) Vol. 267, pp. 113635-113635
Closed Access | Times Cited: 86
Revealing the role of miRNA-489 as a new onco-suppressor factor in different cancers based on pre-clinical and clinical evidence
Mahshid Deldar Abad Paskeh, Sepideh Mirzaei, Sima Orouei, et al.
International Journal of Biological Macromolecules (2021) Vol. 191, pp. 727-737
Closed Access | Times Cited: 43
Isoliquiritigenin inhibits gastric cancer growth through suppressing GLUT4 mediated glucose uptake and inducing PDHK1/PGC-1α mediated energy metabolic collapse
Mingzhu Yu, Qiaoling Pan, Wenbiao Li, et al.
Phytomedicine (2023) Vol. 121, pp. 155045-155045
Closed Access | Times Cited: 16
The trojan horse strategy in T-ALL therapy by engineering T-ALL-derived exosomes for targeted delivery of Isoliquiritigenin to the bone marrow to conquer Drug-Resistant T-ALL in PDX model
Yong Liu, Lindi Li, Cheng Ouyang, et al.
Chemical Engineering Journal (2025), pp. 159379-159379
Open Access
Isoliquiritigenin, an Extract from Licorice, Attenuates Dexamethasone‐Induced Muscle Atrophy via Akt/mTOR Pathway
Xin Jiao, Yuxin Zhang, Zengguang Wang, et al.
Molecular Nutrition & Food Research (2025)
Closed Access
Isoliquiritigenin Nanosuspension Enhances Cytostatic Effects in A549 Lung Cancer Cells
Fangxia Qiao, Yue Zhao, Yaping Mai, et al.
Planta Medica (2020) Vol. 86, Iss. 08, pp. 538-547
Closed Access | Times Cited: 28
Flavokawain C inhibits glucose metabolism and tumor angiogenesis in nasopharyngeal carcinoma by targeting the HSP90B1/STAT3/HK2 signaling axis
YuQiang Hu, Chenjie Yu, Liangjun Cheng, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Isoliquiritigenin Alleviates Diabetic Kidney Disease via Oxidative Stress and the TLR4/NF‐κB/NLRP3 Inflammasome Pathway
Yanhong Wang, Jia Yang, Xinyue Chang, et al.
Molecular Nutrition & Food Research (2024) Vol. 68, Iss. 16
Closed Access | Times Cited: 2
miR-497 regulates fatty acid synthesis via LATS2 in bovine mammary epithelial cells
Zhi Chen, Shuangfeng Chu, Yusheng Liang, et al.
Food & Function (2020) Vol. 11, Iss. 10, pp. 8625-8636
Closed Access | Times Cited: 21
Phytosphingosine inhibits cell proliferation by damaging DNA in human cell lines
Chunxiao Sun, Xuexiu Chang, Hugh J. MacIsaac, et al.
Ecotoxicology and Environmental Safety (2023) Vol. 256, pp. 114840-114840
Open Access | Times Cited: 7
Magic and mystery of microRNA‐32
ZL Zeng, Qingyun Zhu, Zhibo Zhao, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 18, pp. 8588-8601
Open Access | Times Cited: 17
Histone demethylase KDM4A plays an oncogenic role in nasopharyngeal carcinoma by promoting cell migration and invasion
Jingyi Zhao, Bingyan Li, Yongxia Ren, et al.
Experimental & Molecular Medicine (2021) Vol. 53, Iss. 8, pp. 1207-1217
Open Access | Times Cited: 16
A novel and oral colon targeted isoliquiritigenin delivery system: Development, optimization, characterization and in vitro evaluation
Qian Zhao, Xiaoyun Zhang, Xiao Fei Tang, et al.
Journal of Drug Delivery Science and Technology (2021) Vol. 66, pp. 102777-102777
Closed Access | Times Cited: 14
Isoquercitrin promotes ferroptosis and oxidative stress in nasopharyngeal carcinoma via the AMPK/NF‐κB pathway
Xinggu Luo, Yongqian Gong, Qingshan Jiang, et al.
Journal of Biochemical and Molecular Toxicology (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 5
Participation of MicroRNAs in the Treatment of Cancer with Phytochemicals
Seung Wan Son, Han Yeoung Lee, Sokviseth Moeng, et al.
Molecules (2020) Vol. 25, Iss. 20, pp. 4701-4701
Open Access | Times Cited: 15
Isoliquiritigenin regulates the circ_0002860/miR-431-5p/RAB9A axis to function as a tumor inhibitor in melanoma
Songjiang Wu, Jian Wang
˜The œJournal of venomous animals and toxins including tropical diseases (2023) Vol. 29
Open Access | Times Cited: 4
A transcriptomic analysis based on aberrant methylation levels revealed potential novel therapeutic targets for nasopharyngeal carcinoma
Mo Lyu, Xinzhu Yi, Zhiwei Huang, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 2, pp. 47-47
Open Access | Times Cited: 7
<p>Alteration in Expression of miR-32 and FBXW7 Tumor Suppressor in Plasma Samples of Patients with T-cell Acute Lymphoblastic Leukemia</p>
Sanaz Mansouri, Behzad Khansarinejad, Ghasem Mosayebi, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 1253-1259
Open Access | Times Cited: 9
AGT serves as a potential biomarker and drives tumor progression in colorectal carcinoma
Wei Chen, Yihuan Chen, Kai Zhang, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108225-108225
Closed Access | Times Cited: 8
MiRNA signatures in nasopharyngeal carcinoma: molecular mechanisms and therapeutic perspectives.
Yan Chen, Ting Lin, Le Tang, et al.
PubMed (2023) Vol. 13, Iss. 12, pp. 5805-5824
Closed Access | Times Cited: 2
MicroRNA-384 inhibits nasopharyngeal carcinoma growth and metastasis via binding to Smad5 and suppressing the Wnt/β-catenin axis
Xinyu Zeng, Huiqun Liao, Fusen Wang
Cytotechnology (2021) Vol. 73, Iss. 2, pp. 203-215
Open Access | Times Cited: 5
Crosstalk between Non-Coding RNAs and Wnt/β-Catenin Signaling in Head and Neck Cancer: Identification of Novel Biomarkers and Therapeutic Agents
Anjana Sajeev, Bandari BharathwajChetty, Ravichandran Vishwa, et al.
Non-Coding RNA (2023) Vol. 9, Iss. 5, pp. 63-63
Open Access | Times Cited: 1
A pH/Time/Pectinase-Dependent Oral Colon-Targeted System Containing Isoliquiritigenin: Pharmacokinetics and Colon Targeting Evaluation in Mice
Xiaofei Tang, Xiaoyun Zhang, Qianqian Zhao
European Journal of Drug Metabolism and Pharmacokinetics (2022) Vol. 47, Iss. 5, pp. 677-686
Closed Access | Times Cited: 2
Anti-tumor effects of isoliquiritigenin in Bcl-2/Bax and PCNA expression of T24 human bladder cancer cells
Zhanbin Huang, Qianmei Wu, Zhong Wang
Archives of Medical Science (2020)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top